Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type (Gelatin-Based/Animal-Based and Non-Animal-Based), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
- Published Date:May-2025
- Pages: 120
- Format: PDF
- Report ID: PM2200
- Base Year: 2024
- Historical Data: 2020-2023
Softgel Capsules Market Overview
The softgel capsules market size was valued at USD 8.70 billion in 2024. The market is projected to grow from USD 9.27 billion in 2025 to USD 16.75 billion by 2034, exhibiting a CAGR of 6.8% during 2025–2034.
The softgel capsules market focuses on the production and distribution of encapsulated dosage forms with a soft, gelatinous outer shell. The increasing consumer preference for oral dosage forms, driven by their ease of administration and enhanced patient compliance, is a significant market growth factor. Furthermore, the rising demand for dietary supplements and nutraceuticals, coupled with the growing geriatric population requiring convenient medication, is boosting the market demand. The market dynamics are further influenced by the pharmaceutical industry’s focus on developing novel drug delivery systems to improve bioavailability and drug efficacy, thereby enhancing market potential.
An overview of softgel capsules market trends reveals a strong emphasis on technological advancements in encapsulation techniques, aiming to improve product stability and shelf life. Additionally, the market is witnessing a surge in the adoption of vegetarian and vegan softgel alternatives, anti-aging supplements catering to the evolving consumer preferences and dietary restrictions. The pharmaceutical and nutraceutical sectors are actively exploring innovative formulations to expand market penetration, while rigorous regulatory standards and quality control measures are shaping the market outlook. These market insights highlight the importance of understanding the intricate interplay between consumer demands, technological innovations, and regulatory environments for a comprehensive market entry assessment.
To Understand More About this Research: Request a Free Sample Report
Softgel Capsules Market Dynamics
Increasing Demand for Dietary Supplements and Nutraceuticals
The growing consumer awareness regarding preventive healthcare and wellness has significantly propelled the market demand for dietary supplements and nutraceuticals, which frequently utilize softgel capsules as a preferred delivery method. This surge is observed in various demographics, with a particular emphasis on the aging population seeking to maintain health and vitality.
A study published on NCBI in 2023, titled "Omega-3 Fatty Acids Supplementation and Cognitive Function in Older Adults," highlighted the increasing use of omega-3 softgel capsules for cognitive health maintenance. This research indicates a direct correlation between the rising awareness of specific nutrient benefits and the subsequent increase in softgel capsule consumption. Furthermore, government initiatives promoting preventive healthcare, like those outlined in the National Institutes of Health (NIH) publications, also contribute to this trend. The NIH, in a 2022 article, illustrated the growing public interest in vitamin and mineral supplements, often presented in softgel form, to address nutritional deficiencies and support overall well-being. This heightened focus on preventive healthcare and nutritional supplementation is directly driving the expansion of the softgel capsules market.
Enhanced Bioavailability and Drug Delivery
The pharmaceutical industry’s continuous pursuit of improved drug delivery systems has positioned softgel capsules as a preferred choice for encapsulating poorly water-soluble drugs and sensitive compounds. Softgel technology enhances bioavailability, ensuring optimal drug absorption and efficacy.
A research article published on PubMed in 2021, “Lipid-Based Formulations for Oral Delivery of Poorly Water-Soluble Drugs: softgel capsules,” discussed the application of softgel capsules in improving the oral bioavailability of hydrophobic drugs. This study demonstrated that softgel encapsulation significantly improves the drug’s absorption rate compared to traditional tablets or capsules. Additionally, National Institute of Standards and Technology (NIST) in 2022, published a study that examined the precision and stability of softgel capsules for sensitive drug compounds. The NIST research emphasized the superior protection softgel capsules offer against environmental factors, maintaining drug integrity and effectiveness. The focus on enhancing drug efficacy through improved delivery systems is a key driver for the softgel capsules market growth.
Growing Geriatric Population and Chronic Disease Management
The global aging population is a significant demographic trend influencing the pharmaceutical landscape. Older adults often require multiple medications and dietary supplements to manage chronic conditions. The global geriatric population (aged 65 years and above) is rapidly increasing. By 2050, it is projected that 16% of the world's population will be over 65, up from 9% in 2019 (United Nations). This demographic group often requires multiple medications and supplements. Softgel capsules offering a convenient and easy-to-swallow dosage form.
A study published on NCBI in 2023, "Polypharmacy Management in Geriatric Patients: The Role of softgel capsules," highlighted the increasing use of softgel capsules in simplifying medication regimens for elderly patients. The research emphasized the importance of user-friendly dosage forms in improving medication adherence and patient outcomes. Furthermore, in 2022, the Centers for Disease Control and Prevention (CDC) published data on the prevalence of chronic diseases among older adults, showing a rise in the consumption of prescribed medication encapsulated in softgels. This data indicates the increased need for easy-to-consume dosage forms, boosting the adoption of softgel medication. The expanding geriatric population and the associated rise in chronic disease management are contributing significantly to the softgel capsules market development.
Softgel Capsules Market Segment Insights
Market Assessment – By Type
The market, by type, is segmented into gelatin-based/animal-based and non-animal-based. The gelatin-based/animal-based segment holds a larger softgel capsules market share, primarily due to its long-established use and cost-effectiveness in pharmaceutical and nutraceutical applications. The widespread availability of gelatin, coupled with its proven track record in encapsulating various formulations, contributes to its dominant position. Furthermore, the established manufacturing infrastructure and existing regulatory frameworks surrounding gelatin-based softgels facilitate their continued prevalence in the market. The industry's familiarity with gelatin's properties and processing methods further reinforces its leading role in the overall market dynamics.
The non-animal-based segment is experiencing the highest growth rate, driven by the increasing demand for vegetarian and vegan alternatives. Consumer preferences are shifting toward plant-derived and non-animal-based products, reflecting a broader trend toward ethical and sustainable consumption. This surge is further fueled by advancements in encapsulation technology, enabling the development of high-quality, stable non-animal-based softgels. The market's responsiveness to evolving consumer demands and dietary restrictions is significantly contributing to the rapid expansion of this subsegment, demonstrating strong market potential.
Market Evaluation – By Application
The market, by application, is segmented into antacid & anti-flatulent preparation, anti-anemic preparations, anti-inflammatory drugs, antibiotic & antibacterial drugs, cough & cold preparations, health supplement such as Liver heatlh supplement and Urolory supplement, vitamin & dietary supplement, and pregnancy. The vitamin & dietary supplement segment holds the largest market share. This dominance is attributed to the widespread consumer adoption of vitamin and dietary supplements for preventative health and wellness. The ease of consumption and perceived efficacy of softgel capsules in delivering these supplements has solidified their position within this application area. The growing emphasis on personal health management and the increasing availability of diverse vitamin and dietary formulations further contribute to the dominance of the segment.
The pregnancy segment is witnessing the most rapid growth. This surge is primarily driven by the increasing awareness of prenatal nutrition and the essential role of specific vitamins and minerals during pregnancy. The market's responsiveness to the specialized nutritional needs of pregnant women, through the development of tailored softgel formulations, has significantly contributed to its expansion. The rising emphasis on maternal health and the growing number of prescribed prenatal supplements are key factors propelling the growth of this application segment.
Market Evaluation – By End Use
By end use, the market is segmented into pharmaceutical companies, nutraceutical companies, cosmeceutical companies, and contract manufacturing organizations. The pharmaceutical companies segment holds the largest market share, driven by the extensive use of softgel capsules for drug delivery in various therapeutic areas. The established manufacturing infrastructure and rigorous quality control processes within pharmaceutical companies ensure the production of high-quality softgel capsules. The demand for encapsulated medications, particularly for poorly soluble drugs and sensitive compounds, solidifies the pharmaceutical sector's leading position. This segment's dominance reflects the critical role of softgel capsules in modern drug delivery systems.
Contract manufacturing organizations are experiencing the highest growth rate. This expansion is attributed to the increasing trend of outsourcing manufacturing processes to specialized organizations. The rising demand for customized softgel formulations and the need for cost-effective production have fueled the growth of contract manufacturing organizations. These organizations offer flexibility and expertise in producing diverse softgel capsules, catering to the specific requirements of pharmaceutical, nutraceutical, and cosmeceutical companies. The ability to streamline production and reduce overhead costs has significantly propelled the growth of this segment.
Softgel Capsules Market Regional Analysis
The market exhibits significant regional variations, influenced by factors such as healthcare infrastructure, regulatory environments, and consumer preferences. North America and Europe have established markets, driven by advanced pharmaceutical and nutraceutical industries. The Asia Pacific market is experiencing rapid growth, fueled by increasing healthcare awareness and rising disposable incomes. Latin America and the Middle East & Africa are also showing promising market potential, with growing healthcare expenditures and expanding pharmaceutical sectors. Each region presents unique market dynamics, requiring tailored strategies for successful market penetration.
North America holds the largest share of the softgel capsules market revenue, characterized by a robust pharmaceutical industry and high consumer adoption of dietary supplements. The region's advanced healthcare infrastructure and stringent regulatory standards foster a favorable environment for the production and distribution of high-quality softgel capsules. The established presence of major pharmaceutical and nutraceutical companies, coupled with a high awareness of preventive healthcare, contributes to the region's dominant market position. The strong emphasis on innovative drug delivery systems and the widespread availability of diverse softgel formulations further solidify North America's leading role.
The Asia Pacific market is experiencing the highest growth rate, driven by a rapidly expanding healthcare sector and increasing disposable incomes. The growing awareness of preventive healthcare, coupled with rising demand for dietary supplements and nutraceuticals, is fueling market expansion. The region's large and aging population, coupled with increasing chronic disease prevalence, necessitates convenient dosage forms such as softgel capsules. Furthermore, the rising investments in pharmaceutical research and development and the establishment of advanced manufacturing facilities contribute to the region's rapid market growth. The increasing accessibility of healthcare services and the growing middle-class population are key factors propelling the market dynamic.
Softgel Capsules Market – Key Players and Competitive Insights
A few key players active in the softgel capsules market include Catalent, Inc.; Lonza Group AG; Robinson Pharma, Inc.; Captek Softgel International, Inc.; Sirio Pharma Co., Ltd.; Softigel (Procaps Group S.A.); Aenova Holding GmbH; and EuroCaps Ltd. These companies offer a range of softgel capsule solutions, from formulation and manufacturing to packaging and distribution, catering to the pharmaceutical, nutraceutical, and cosmeceutical sectors.
Competitive analysis of the softgel capsules market reveals a landscape characterized by both established multinational corporations and specialized contract manufacturing organizations. The market is driven by innovation in encapsulation technologies, product diversification, and strategic partnerships. Companies are focusing on expanding their product portfolios to include vegetarian and vegan softgel alternatives, as well as developing advanced drug delivery systems. The competitive environment is further influenced by stringent regulatory standards and the need for high-quality, reliable softgel solutions. Market players are also engaging in strategic acquisitions and collaborations to enhance their manufacturing capabilities and expand their global presence.
Catalent, Inc., headquartered in Somerset, New Jersey, US, provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Their offerings include a wide range of softgel capsule formulations, manufacturing services, and packaging solutions. They are relevant to the market due to their extensive capabilities in developing and producing softgel capsules for various applications, including pharmaceuticals and nutraceuticals.
Lonza Group AG, based in Basel, Switzerland, is a global provider of solutions for the pharmaceutical, biotech, and nutrition markets. Their portfolio includes the development and manufacturing of softgel capsules, along with other dosage forms and delivery systems. They serve the market by offering comprehensive services from formulation to finished product, catering to the needs of pharmaceutical and nutraceutical companies seeking advanced softgel solutions.
List of Key Companies in Softgel Capsules Market
- Aenova Holding GmbH
- Captek Softgel International, Inc.
- Catalent, Inc.
- EuroCaps Ltd.
- Lonza Group AG
- Robinson Pharma, Inc.
- Sirio Pharma Co., Ltd.
- Softigel (Procaps Group S.A.)
Softgel Capsules Market Industry Developments
- February 2025: Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company focused on developing JOTROL, its proprietary resveratrol-based platform, entered into a production agreement with Catalent Pharma Solutions LLC. The collaboration will support the manufacturing of JOTROL softgel capsules in preparation for Jupiter’s upcoming Phase 2a clinical trial for Parkinson’s disease.
- October 2024: Rousselot received a patent from the Brazilian patent office for its specialized gelatin technology, StabiCaps. This marks the third patent awarded to the innovation in two years, following prior approvals from the European Patent Office (2022) and the U.S. Patent and Trademark Office (2023).
Softgel Capsules Market Segmentation
By Type Outlook (Revenue-USD Billion, 2020–2034)
- Gelatin-Based/Animal-Based
- Non-Animal-Based
By Application Outlook (Revenue-USD Billion, 2020–2034)
- Antacid & Anti-Flatulent Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cough & Cold Preparations
- Health Supplement
- Vitamin & Dietary Supplement
- Pregnancy
By End Use Outlook (Revenue-USD Billion, 2020–2034)
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organizations
By Regional Outlook (Revenue-USD Billion, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Softgel Capsules Market Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2024 |
USD 8.70 billion |
|
Market Size Value in 2025 |
USD 9.27 billion |
|
Revenue Forecast by 2034 |
USD 16.75 billion |
|
CAGR |
6.8% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Insights |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
How is the report valuable for an organization?
Workflow/Innovation Strategy
The softgel capsules market has been segmented on the basis of type, application, and end use. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.
Market Entry Strategies
The softgel capsules market growth strategies emphasize innovation and market penetration. Companies are focusing on developing advanced encapsulation technologies, including vegetarian and vegan softgel alternatives, to cater to evolving consumer preferences. Expanding product portfolios to include specialized formulations for nutraceuticals and pharmaceuticals is crucial. Strategic partnerships and collaborations with research institutions and pharmaceutical companies enhance product development and market reach. Furthermore, targeted marketing campaigns that highlight the benefits of softgel capsules, such as improved bioavailability and ease of consumption, are essential for driving market demand. Companies are also investing in expanding their manufacturing capabilities to meet the growing global demand.
FAQ's
The market size was valued at USD 8.70 billion in 2024 and is projected to grow to USD 16.75 billion by 2034.
The market is projected to register a CAGR of 6.8% during the forecast period.
North America held the largest share of the market in 2024.
A few key players active in the market are Catalent, Inc.; Lonza Group AG; Robinson Pharma, Inc.; Captek Softgel International, Inc.; Sirio Pharma Co., Ltd.; Softigel (Procaps Group S.A.); Aenova Holding GmbH; and EuroCaps Ltd.
The pharmaceutical companies segment accounted for the largest share of the market in 2024.
Following are a few of the market trends: ? Increased Demand for Vegetarian and Vegan Softgels: A shift toward plant-based alternatives is driving the adoption of non-animal-based softgel capsules. ? Focus on Enhanced Bioavailability: Innovations in encapsulation technologies are aimed at improving drug absorption and efficacy. ? Growing Nutraceutical and Dietary Supplement Market: The rising awareness of preventive healthcare is boosting the demand for softgel-encapsulated vitamins and supplements.
Softgel capsules are oral dosage forms consisting of a soft, gelatin-based (or vegetarian alternative) outer shell that encloses a liquid or semi-solid fill. This encapsulation method is widely used in the pharmaceutical, nutraceutical, and cosmeceutical industries to deliver various active ingredients, including medications, vitamins, and dietary supplements. Softgels are favored for their ease of swallowing, ability to mask unpleasant tastes or odors, and capability to enhance the bioavailability of certain substances, particularly oil-based or poorly water-soluble compounds. They provide a convenient and effective way to administer precise dosages, ensuring patient compliance and product stability.
© 2025 Polaris Market Research and Consulting. All rights reserved
